Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)
A Pilot Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary SPECT
Status: Enrolling
Updated:  7/10/2014
University of Michigan Comprehensive Cancer Center
808
mi
from
Ann Arbor, MI
A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)
A Pilot Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary SPECT
Status: Enrolling
Updated: 7/10/2014
University of Michigan Comprehensive Cancer Center
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
SPY Intra-Operative Angiography & Skin Perfusion in Immediate Breast Reconstruction w/ Implants
The Role of SPY Intra-Operative Angiography in Determining Adequate Skin Perfusion in Immediate Breast Reconstruction With Implants
Status: Enrolling
Updated:  7/14/2014
Stanford University School of Medicine
1329
mi
from
Stanford, CA
SPY Intra-Operative Angiography & Skin Perfusion in Immediate Breast Reconstruction w/ Implants
The Role of SPY Intra-Operative Angiography in Determining Adequate Skin Perfusion in Immediate Breast Reconstruction With Implants
Status: Enrolling
Updated: 7/14/2014
Stanford University School of Medicine
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Goals of Care Discussions for Hospitalized Patients With Advanced Cancer
Gender Differences in Inpatient Goals of Care Discussions in Patients With Advanced Cancer
Status: Enrolling
Updated:  7/15/2014
Northwestern Memorial Hospital
611
mi
from
Chicago, IL
Goals of Care Discussions for Hospitalized Patients With Advanced Cancer
Gender Differences in Inpatient Goals of Care Discussions in Patients With Advanced Cancer
Status: Enrolling
Updated: 7/15/2014
Northwestern Memorial Hospital
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated:  7/22/2014
Mobile Infirmary Medical Center
737
mi
from
Mobile, AL
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated: 7/22/2014
Mobile Infirmary Medical Center
737
mi
from
Mobile, AL
Click here to add this to my saved trials
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated:  7/22/2014
The Pancreas and Biliary Center of South Florida
1299
mi
from
Boca Raton, FL
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated: 7/22/2014
The Pancreas and Biliary Center of South Florida
1299
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated:  7/22/2014
Borland-Groover Clinic
1062
mi
from
Jacksonville, FL
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated: 7/22/2014
Borland-Groover Clinic
1062
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated:  7/22/2014
The Florida Hospital
1139
mi
from
Orlando, FL
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated: 7/22/2014
The Florida Hospital
1139
mi
from
Orlando, FL
Click here to add this to my saved trials
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated:  7/22/2014
Northwest Community Hospital
600
mi
from
Arlington Heights, IL
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated: 7/22/2014
Northwest Community Hospital
600
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated:  7/22/2014
Univ of Massachusetts Med School
1405
mi
from
Worcester, MA
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated: 7/22/2014
Univ of Massachusetts Med School
1405
mi
from
Worcester, MA
Click here to add this to my saved trials
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated:  7/22/2014
SUNY at Stony Brook Hospital
1333
mi
from
Stony Brook, NY
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated: 7/22/2014
SUNY at Stony Brook Hospital
1333
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated:  7/22/2014
Digestive Associates of Houston
572
mi
from
Houston, TX
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated: 7/22/2014
Digestive Associates of Houston
572
mi
from
Houston, TX
Click here to add this to my saved trials
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated:  7/22/2014
Aurora Saint Lukes Medical Center
633
mi
from
Milwaukee, WI
Evolution® Biliary Stent System Clinical Study
Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
Status: Enrolling
Updated: 7/22/2014
Aurora Saint Lukes Medical Center
633
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Northern AZ Hematology and Oncology Associates
803
mi
from
Sedona, AZ
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Northern AZ Hematology and Oncology Associates
803
mi
from
Sedona, AZ
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Healing Hands Oncology and Medical Care
1178
mi
from
Hawthorne, CA
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Healing Hands Oncology and Medical Care
1178
mi
from
Hawthorne, CA
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
University of Southern California
1166
mi
from
Los Angeles, CA
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
University of Southern California
1166
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Comprehensive Cancer Center
1081
mi
from
Palm Springs, CA
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Comprehensive Cancer Center
1081
mi
from
Palm Springs, CA
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Comprehensive Cancer Care Specialist of Boca
1293
mi
from
Boca Raton, FL
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Comprehensive Cancer Care Specialist of Boca
1293
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Robert R. Carroll, MD, PA
1045
mi
from
Gainesville, FL
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Robert R. Carroll, MD, PA
1045
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Hematology Oncology Associates
1288
mi
from
Lake Worth, FL
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Hematology Oncology Associates
1288
mi
from
Lake Worth, FL
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Medical Specialists Of Palm Beaches
1283
mi
from
Lake Worth, FL
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Medical Specialists Of Palm Beaches
1283
mi
from
Lake Worth, FL
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Ocala Oncology Center
1078
mi
from
Ocala, FL
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Ocala Oncology Center
1078
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Hematology Oncology Associates Of The Treasure Coast
1247
mi
from
Port St. Lucie, FL
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Hematology Oncology Associates Of The Treasure Coast
1247
mi
from
Port St. Lucie, FL
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Oncology and Hematology Associates of West Broward
1298
mi
from
Tamarac, FL
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Oncology and Hematology Associates of West Broward
1298
mi
from
Tamarac, FL
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Hematology-Oncology Associates of Illinois
611
mi
from
Chicago, IL
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Hematology-Oncology Associates of Illinois
611
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Decatur Memorial Hospital
499
mi
from
Decatur, IL
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Decatur Memorial Hospital
499
mi
from
Decatur, IL
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Central Indiana Cancer Centers
644
mi
from
Indianapolis, IN
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Central Indiana Cancer Centers
644
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Heartland Oncology and Hematology
265
mi
from
Council Bluffs, IA
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Heartland Oncology and Hematology
265
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Hematology and Oncology Specialists
699
mi
from
Marrero, LA
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Hematology and Oncology Specialists
699
mi
from
Marrero, LA
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Metairie Institute of Comprehensive Health
690
mi
from
Metairie, LA
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Metairie Institute of Comprehensive Health
690
mi
from
Metairie, LA
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Hematology and Oncology Specialists
698
mi
from
New Orleans, LA
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Hematology and Oncology Specialists
698
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Maryland Oncology Hematology PA
1134
mi
from
Columbia, MD
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Maryland Oncology Hematology PA
1134
mi
from
Columbia, MD
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Washington County Hospital
1088
mi
from
Hagerstown, MD
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Washington County Hospital
1088
mi
from
Hagerstown, MD
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Josephine Ford Cancer Center
mi
from
Brownstown, MI
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Josephine Ford Cancer Center
mi
from
Brownstown, MI
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Henry Ford Medical Center- Fairlane
835
mi
from
Dearborn, MI
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Henry Ford Medical Center- Fairlane
835
mi
from
Dearborn, MI
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Henry Ford Health Systems
841
mi
from
Detroit, MI
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Henry Ford Health Systems
841
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Henry Ford Medical Center Farmington
829
mi
from
West Bloomfield, MI
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Henry Ford Medical Center Farmington
829
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Summit Medical Group
1263
mi
from
Berkeley Heights, NJ
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Summit Medical Group
1263
mi
from
Berkeley Heights, NJ
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Joan Knechel Cancer Center
1244
mi
from
Mt. Arlington, NJ
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Joan Knechel Cancer Center
1244
mi
from
Mt. Arlington, NJ
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Montefiore Medical Center
1293
mi
from
Bronx, NY
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Montefiore Medical Center
1293
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Queens Cancer Center of Queens Hospital
1297
mi
from
Jamaica, NY
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Queens Cancer Center of Queens Hospital
1297
mi
from
Jamaica, NY
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Saint Vincent's Comprehensive Cancer Center
1286
mi
from
New York, NY
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Saint Vincent's Comprehensive Cancer Center
1286
mi
from
New York, NY
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Weil Cornell Breast Center
1289
mi
from
New York, NY
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Weil Cornell Breast Center
1289
mi
from
New York, NY
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Charleston Hematology Oncology Associates PA
1062
mi
from
Charleston, NC
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Charleston Hematology Oncology Associates PA
1062
mi
from
Charleston, NC
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Cancer Center of North Carolina
1068
mi
from
Raleigh, NC
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Cancer Center of North Carolina
1068
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Northwest Cancer Specialists Rose Quarter
1383
mi
from
Portland, OR
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Northwest Cancer Specialists Rose Quarter
1383
mi
from
Portland, OR
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Northwest Cancer Specialists, P.C. - Hoyt
1380
mi
from
Portland, OR
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Northwest Cancer Specialists, P.C. - Hoyt
1380
mi
from
Portland, OR
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Northwest Cancer Specialists, PC
1385
mi
from
Tualatin, OR
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Northwest Cancer Specialists, PC
1385
mi
from
Tualatin, OR
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Lone Star Oncology
507
mi
from
Austin, TX
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Lone Star Oncology
507
mi
from
Austin, TX
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
South Texas Institute of Cancer
682
mi
from
Corpus Christi, TX
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
South Texas Institute of Cancer
682
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated:  7/22/2014
Northwest Cancer Center
683
mi
from
Corpus Christi, TX
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/22/2014
Northwest Cancer Center
683
mi
from
Corpus Christi, TX
Click here to add this to my saved trials